Latest profit margin for BioAdaptives: -4553.73% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
BioAdaptives's profit margin stands at -4553.73% as of June 2026. That compares with 2084.8% in the prior-year period — down 318.4% year over year. That is below the sector sector average of 13.23%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
BioAdaptives reported -4553.73% in profit margin versus 2084.8% a year earlier — a 318.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
BioAdaptives sits lower the its sector benchmark (13.23%) with a profit margin of -4553.73%. That is roughly 34529.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -4553.73% for BioAdaptives means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how BioAdaptives's profit margin evolved across reporting periods, while the comparison chart places BDPT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.